Allo-HSCT May Be Beneficial in Patients With Relapsed/Refractory AML
Researchers sought to determine whether allo-HSCT would be beneficial for survival in patients with relapsed/refractory AML.
All articles by Ryner Lai
Patients With Polycythemia Vera Mostly Remain in Target Hematocrit Range
Researchers sought to assess current management guidelines for patients with polycythemia vera in terms of target hematocrit levels.
Managing Acute Vaso-Occlusive Crises in Sickle Cell Disease
Researchers have sought to determine better ways to manage patients with SCD experiencing pain or a vaso-occlusive sickle cell crisis.
Pregnant Patients Receiving Iron Supplements Have Substantial Improvements in Hematologic Indices
The rate of maternal anemia was lower in the cohort receiving iron supplements compared with the previous cohort upon admission and prior to discharge.
Sex, Healthcare Utilization for Acute Pain Associated With Hospitalization Among Adolescents With SCD
Researchers sought to determine whether there is a link between patient sex and HCU for acute pain trajectories in adolescents with SCD.
Coping Methods Mediate Resilience in Young Adults and Adolescents With Thalassemia
Researchers sought to determine how different responses to chronic disease interact to produce resilience among patients with thalassemia.
C5 Inhibitors Provide Inadequate Disease Control in PNH
Researchers sought to determine the real-world treatment patterns and outcomes associated with the use of C5 inhibitors in patients with PNH.
Improving Hemoglobin Levels May Lead to Improved Neurocognition and Educational Outcomes Among Children With SCD
Researchers sought to determine whether improving hemoglobin levels in children with SCD would improve neurocognition and educational outcomes.
Ebselen Potentially Alleviates Cardiomyopathy in Iron-Overloaded Thalassemia
Researchers sought to determine whether ebselen would alleviate cardiomyopathy in patients with iron-overloaded thalassemia.
Eltrombopag Appears Safe and Effective in Treating Severe Thrombocytopenia in Low-Risk MDS
Researchers sought to determine whether eltrombopag would alleviate thrombocytopenia in patients with low-risk myelodysplastic syndrome.
- Loading...
Loading...
Next post in Myelodysplastic Syndromes
Loading... 
Loading...